The high MYCN dosage obtained with MYCNΔ1b mRNA translation induces, in transfected SH-EP neuroblastoma cells, a weak but significant antiapoptotic effect after serum deprivation that was not observed with low MYCN expression. The gene discussed is MYCN; the disease is neuroblastoma.